Page last updated: 2024-08-23

paclitaxel and Polycystic Kidney Diseases

paclitaxel has been researched along with Polycystic Kidney Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (83.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bawumia, S; Chiu, MG; Dahm-Vicker, EM; Guay-Woodford, L; Hillman, KA; Hughes, RC; Johnson, TM; Long, DA; Poirier, F; Venner, K; Winyard, PJ; Woolf, AS1
Woolf, AS1
Miao, SY; Pelayo, JC; Woo, DD; Woolf, AS1
Cowley, BD; Gattone, VH; Grantham, JJ; Kaneta, S; Martinez, JR; Nagao, S; Takahashi, H; Yamaguchi, T1
Tabancay, AP; Wang, CJ; Woo, DD1
Avner, ED; Sommardahl, CS; Sweeney, WE; Wilkinson, JE; Woychik, RP1

Other Studies

6 other study(ies) available for paclitaxel and Polycystic Kidney Diseases

ArticleYear
Galectin-3 associates with the primary cilium and modulates cyst growth in congenital polycystic kidney disease.
    The American journal of pathology, 2006, Volume: 169, Issue:6

    Topics: Animals; Animals, Genetically Modified; Cells, Cultured; Centrosome; Cilia; Cysts; Galectin 3; Kidney; Kidney Tubules, Collecting; Mice; Mice, Inbred C57BL; Paclitaxel; Polycystic Kidney Diseases

2006
Cures for polycystic kidney diseases?
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1994, Volume: 9, Issue:10

    Topics: Animals; Disease Models, Animal; Humans; Paclitaxel; Polycystic Kidney Diseases

1994
Taxol inhibits progression of congenital polycystic kidney disease.
    Nature, 1994, Apr-21, Volume: 368, Issue:6473

    Topics: Animals; Body Weight; Cells, Cultured; Disease Models, Animal; Humans; Kidney; Mice; Microtubules; Organ Size; Paclitaxel; Polycystic Kidney Diseases

1994
The effect of paclitaxel on the progression of polycystic kidney disease in rodents.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1997, Volume: 29, Issue:3

    Topics: Animals; Disease Progression; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Heterozygote; Homozygote; Kidney; Male; Mice; Mice, Inbred C57BL; Paclitaxel; Polycystic Kidney Diseases; Random Allocation; Rats; Rats, Inbred Strains; Renal Agents

1997
Microtubule active taxanes inhibit polycystic kidney disease progression in cpk mice.
    Kidney international, 1997, Volume: 51, Issue:5

    Topics: Alkaloids; Animals; Kidney; Mice; Mice, Inbred C57BL; Microtubules; Paclitaxel; Polycystic Kidney Diseases; Structure-Activity Relationship; Taxoids

1997
Efficacy of taxol in the orpk mouse model of polycystic kidney disease.
    Pediatric nephrology (Berlin, Germany), 1997, Volume: 11, Issue:6

    Topics: Aging; Alkaline Phosphatase; Animals; Antineoplastic Agents, Phytogenic; ErbB Receptors; Genes; Immunohistochemistry; Kidney; Liver; Mice; Mutation; Osmolar Concentration; Paclitaxel; Polycystic Kidney Diseases

1997